Minimal (Trophic) Feeding

BEHAVIORAL2 trials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)

Conditions

Respiratory Distress Syndrome, Adult

Phase 3

Early Versus Delayed Enteral Feeding and Omega-3 Fatty Acid/Antioxidant Supplementation for Treating People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN-Omega Study)

TerminatedNCT00609180

National Heart, Lung, and Blood Institute (NHLBI)Respiratory Distress Syndrome, Adult

Start: 2007-12-31End: 2009-04-30Updated: 2016-04-13

Early Versus Delayed Enteral Feeding to Treat People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN Study)

CompletedNCT00883948

National Heart, Lung, and Blood Institute (NHLBI)Respiratory Distress Syndrome, Adult

Start: 2007-12-31End: 2011-05-31Updated: 2016-04-13

Related Papers

Impact of rs174537 on Critically Ill Patients with Acute Lung Injury: A Secondary Analysis of the OMEGA Randomized Clinical Trial.

2020-09-143 citations

The Impact of <i>FADS</i> Variants on Responses to Diet in Patients With ALI

The FASEB Journal2019-04-01

Predictors of 6-month health utility outcomes in survivors of acute respiratory distress syndrome

Thorax2016-07-2038 citations

Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial.

2012-02-05599 citations

Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury.

2011-10-05343 citations

Enteral nutrition with eicosapentaenoic acid, γ-linolenic acid and antioxidants in the early treatment of sepsis: results from a multicenter, prospective, randomized, double-blinded, controlled study: the INTERSEPT study.

2011-06-0985 citations